Back to today’s briefing

Story perspectives

Rising Kratom Deaths Prompt Urgent Regulatory Action

9/23/2025

26 6

Summary

Story summary

Kratom-linked deaths, including Jordan McKibban’s in 2022, prompt warnings and regulatory scrutiny.
The FDA cautions against kratom, citing potential harm and labeling it a drug of concern.
Washington’s Poison Center reports rising kratom incidents, especially linked to the potent compound 7-hydroxymitragynine (7-OH).
Montana Rep. Jodee Etchart calls for immediate state action to regulate 7-OH products.

1 of 1

Story summary

Kratom-linked deaths, including Jordan McKibban’s in 2022, prompt warnings and regulatory scrutiny.
The FDA cautions against kratom, citing potential harm and labeling it a drug of concern.
Washington’s Poison Center reports rising kratom incidents, especially linked to the potent compound 7-hydroxymitragynine (7-OH).
Montana Rep. Jodee Etchart calls for immediate state action to regulate 7-OH products.